EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The ARIES Study: A Randomized Clinical Trial.

Authors:
Mitchell P; Holz FG; Hykin P; Midena E; Souied E and 5 more

Journal:
Retina

Publication Year: 2021

DOI:
10.1097/IAE.0000000000003128

PMCID:
PMC8384251

PMID:
33782365

Journal Information

Full Title: Retina

Abbreviation: Retina

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"P. Mitchell has received consulting fees from Bayer, Novartis, and Allergan and is an ARIES Steering Committee member. F. Holz has served as a consultant for Acucela, Apellis Pharmaceuticals, Bayer, Boehringer-Ingelheim, Bioeq/Formycon AG, Roche/Genentech, Geuder AG, Graybug Vision, Heidelberg Engineering, Chengdu Kanghong Pharmaceuticals, Lin Bioscience, Novartis, Pixium Vision, Oxurion, and Stealth BioTherapeutics; has received research support from Acucela, Apellis Pharmaceuticals, Bayer, Bioeq/Formycon AG, CenterVue, Roche/Genentech, Heidelberg Engineering, Chengdu Kanghong Pharmaceuticals, NightstaRx, Novartis, Optos, Pixium Vision, and Zeiss Pharma; has received honoraria or travel reimbursement from Acucela, Apellis Pharmaceuticals, Bayer, Ellex, Roche/Genentech, Graybug Vision, Heidelberg Engineering, Lin Bioscience, Novartis, Pixium Vision, Oxurion, Stealth BioTherapeutics, and Zeiss Pharma; and is an ARIES Steering Committee member. P. Hykin has received consultant fees from Bayer HealthCare, Novartis, and Allergan; has received travel support to participate in review activities for meetings from Bayer; has received support for provision of writing assistance, medicines, equipment, or administrative support from Bayer; has received payment for lectures and support for conference attendance from Allergan and Novartis; and is an ARIES Steering Committee member. S. Wolf has served as a consultant for Allergan, Bayer, Boehringer-Ingelheim, Chengdu Kanghong Biotech, Heidelberg Engineering, Novartis, Oxurion, Zeiss, and Roche; has received grant support from Heidelberg Engineering; and is an ARIES Steering Committee member. H. Allmeier, G. Lambrou, and T. Schmelter are employees of Bayer. T. Schmelter owns stocks of Bayer AG. E. Souied is an ARIES Steering Committee member. E. Midena is an ARIES Steering Committee member."

Evidence found in paper:

"Medical writing and editorial support for the preparation of this article was funded by Bayer Consumer Care AG, Switzerland. This study was sponsored by Bayer HealthCare AG, Germany."

Evidence found in paper:

"Trial Registration: ClinicalTrials.gov Identifier: NCT02581891 https://clinicaltrials.gov/ct2/show/NCT02581891. Supplemental Digital Contents (files 1 http://links.lww.com/IAE/B419)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025